Research ArticleCELLULAR AND MOLECULAR
Roflumilast Inhibits Lipopolysaccharide-Induced Inflammatory Mediators via Suppression of Nuclear Factor-κB, p38 Mitogen-Activated Protein Kinase, and c-Jun NH2-Terminal Kinase Activation
Hyun Jeong Kwak, Jin Sook Song, Jun Young Heo, Sung Don Yang, Ji-Youn Nam and Hyae Gyeong Cheon
Journal of Pharmacology and Experimental Therapeutics December 2005, 315 (3) 1188-1195; DOI: https://doi.org/10.1124/jpet.105.092056
Hyun Jeong Kwak
Jin Sook Song
Jun Young Heo
Sung Don Yang
Ji-Youn Nam
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleCELLULAR AND MOLECULAR
Roflumilast Inhibits Lipopolysaccharide-Induced Inflammatory Mediators via Suppression of Nuclear Factor-κB, p38 Mitogen-Activated Protein Kinase, and c-Jun NH2-Terminal Kinase Activation
Hyun Jeong Kwak, Jin Sook Song, Jun Young Heo, Sung Don Yang, Ji-Youn Nam and Hyae Gyeong Cheon
Journal of Pharmacology and Experimental Therapeutics December 1, 2005, 315 (3) 1188-1195; DOI: https://doi.org/10.1124/jpet.105.092056
Research ArticleCELLULAR AND MOLECULAR
Roflumilast Inhibits Lipopolysaccharide-Induced Inflammatory Mediators via Suppression of Nuclear Factor-κB, p38 Mitogen-Activated Protein Kinase, and c-Jun NH2-Terminal Kinase Activation
Hyun Jeong Kwak, Jin Sook Song, Jun Young Heo, Sung Don Yang, Ji-Youn Nam and Hyae Gyeong Cheon
Journal of Pharmacology and Experimental Therapeutics December 1, 2005, 315 (3) 1188-1195; DOI: https://doi.org/10.1124/jpet.105.092056
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement